150 related articles for article (PubMed ID: 9760316)
1. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle.
Norman B; Mahnke-Zizelman DK; Vallis A; Sabina RL
J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316
[TBL] [Abstract][Full Text] [Related]
2. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle.
Hanisch F; Hellsten Y; Zierz S
Biol Chem; 2006 Jan; 387(1):53-8. PubMed ID: 16497164
[TBL] [Abstract][Full Text] [Related]
3. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
[TBL] [Abstract][Full Text] [Related]
4. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
[TBL] [Abstract][Full Text] [Related]
5. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.
Norman B; Sabina RL; Jansson E
J Appl Physiol (1985); 2001 Jul; 91(1):258-64. PubMed ID: 11408438
[TBL] [Abstract][Full Text] [Related]
6. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
Fortuin FD; Morisaki T; Holmes EW
Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
[TBL] [Abstract][Full Text] [Related]
7. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
[TBL] [Abstract][Full Text] [Related]
8. The effect of AMPD1 genotype on blood flow response to sprint exercise.
Norman B; Nygren AT; Nowak J; Sabina RL
Eur J Appl Physiol; 2008 May; 103(2):173-80. PubMed ID: 18224333
[TBL] [Abstract][Full Text] [Related]
9. Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme.
Ronca F; Raggi A
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142952
[TBL] [Abstract][Full Text] [Related]
10. Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.
Mahnke-Zizelman DK; D'cunha J; Wojnar JM; Brogley MA; Sabina RL
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):521-9. PubMed ID: 9291127
[TBL] [Abstract][Full Text] [Related]
11. Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.
Goodarzi MO; Taylor KD; Guo X; Quiñones MJ; Cui J; Li X; Hang T; Yang H; Holmes E; Hsueh WA; Olefsky J; Rotter JI
Diabetes; 2005 Apr; 54(4):1222-7. PubMed ID: 15793265
[TBL] [Abstract][Full Text] [Related]
12. AMPD1: a novel therapeutic target for reversing insulin resistance.
Cheng J; Morisaki H; Toyama K; Sugimoto N; Shintani T; Tandelilin A; Hirase T; Holmes EW; Morisaki T
BMC Endocr Disord; 2014 Dec; 14():96. PubMed ID: 25511531
[TBL] [Abstract][Full Text] [Related]
13. DNA sequence polymorphism within the bovine adenosine monophosphate deaminase 1 (AMPD1) is associated with production traits in Chinese cattle.
Wei CB; Wang JQ; Chen FY; Niu H; Li K
Genet Mol Res; 2015 Feb; 14(1):1025-33. PubMed ID: 25730042
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle contraction kinetics and AMPK responses are modulated by the adenine nucleotide degrading enzyme AMPD1.
Hafen PS; Law AS; Matias C; Miller SG; Brault JJ
J Appl Physiol (1985); 2022 Nov; 133(5):1055-1066. PubMed ID: 36107988
[TBL] [Abstract][Full Text] [Related]
15. Alterations in AMP deaminase activity and kinetics in skeletal muscle of creatine kinase-deficient mice.
Tullson PC; Rush JW; Wieringa B; Terjung RL
Am J Physiol; 1998 May; 274(5):C1411-6. PubMed ID: 9612229
[TBL] [Abstract][Full Text] [Related]
16. Effect of AMPD1 gene polymorphism on muscle activity in humans.
Fedotovskaya ON; Danilova AA; Akhmetov II
Bull Exp Biol Med; 2013 Feb; 154(4):489-91. PubMed ID: 23486588
[TBL] [Abstract][Full Text] [Related]
17. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
18.
Leońska-Duniec A; Maculewicz E; Humińska-Lisowska K; Maciejewska-Skrendo A; Leźnicka K; Cięszczyk P; Sawczuk M; Trybek G; Wilk M; Lepionka W; Ficek K
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32429460
[TBL] [Abstract][Full Text] [Related]
19. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.
Rico-Sanz J; Rankinen T; Joanisse DR; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C;
Physiol Genomics; 2003 Jul; 14(2):161-6. PubMed ID: 12783984
[TBL] [Abstract][Full Text] [Related]
20. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
Loh E; Rebbeck TR; Mahoney PD; DeNofrio D; Swain JL; Holmes EW
Circulation; 1999 Mar; 99(11):1422-5. PubMed ID: 10086964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
